BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 19708033)

  • 1. Prognosis and patterns of care in elderly patients with glioma.
    Iwamoto FM; Reiner AS; Nayak L; Panageas KS; Elkin EB; Abrey LE
    Cancer; 2009 Dec; 115(23):5534-40. PubMed ID: 19708033
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effectiveness of radiotherapy for elderly patients with anaplastic gliomas.
    Mukherjee D; Sarmiento JM; Nosova K; Boakye M; Lad SP; Black KL; Nuño M; Patil CG
    J Clin Neurosci; 2014 May; 21(5):773-8. PubMed ID: 24355207
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinicohistological study of oligodendroglioma and oligoastrocytoma.
    Tamura M; Zama A; Kurihara H; Kano T; Imai H; Ishiuchi S; Iwai T; Naito I
    Brain Tumor Pathol; 1997; 14(1):35-9. PubMed ID: 9384800
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The impact of adjuvant radiation therapy for high-grade gliomas by histology in the United States population.
    Rusthoven CG; Carlson JA; Waxweiler TV; Dally MJ; Barón AE; Yeh N; Gaspar LE; Liu AK; Ney DE; Damek DM; Lillehei KO; Kavanagh BD
    Int J Radiat Oncol Biol Phys; 2014 Nov; 90(4):894-902. PubMed ID: 25585784
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Patterns of care and outcomes of patients with pleomorphic xanthoastrocytoma: a SEER analysis.
    Perkins SM; Mitra N; Fei W; Shinohara ET
    J Neurooncol; 2012 Oct; 110(1):99-104. PubMed ID: 22843450
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Population-Based Study of Treatment and Survival in Older Glioma Patients.
    Reiner AS; Lobaugh SM; Gonen S; Diamond EL; Panageas KS
    JNCI Cancer Spectr; 2022 Jan; 6(1):. PubMed ID: 35699501
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Current knowledge and treatment strategies for grade II gliomas.
    Narita Y
    Neurol Med Chir (Tokyo); 2013; 53(7):429-37. PubMed ID: 23883553
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment updates regarding anaplastic oligodendroglioma and anaplastic oligoastrocytoma.
    Khan KA; Abbasi AN; Ali N
    J Coll Physicians Surg Pak; 2014 Dec; 24(12):935-9. PubMed ID: 25523732
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diffuse Infiltrating Oligodendroglioma and Astrocytoma.
    van den Bent MJ; Smits M; Kros JM; Chang SM
    J Clin Oncol; 2017 Jul; 35(21):2394-2401. PubMed ID: 28640702
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Management and Survival Patterns of Patients with Gliomatosis Cerebri: A SEER-Based Analysis.
    Carroll KT; Hirshman B; Ali MA; Alattar AA; Brandel MG; Lochte B; Lanman T; Carter B; Chen CC
    World Neurosurg; 2017 Jul; 103():186-193. PubMed ID: 28366748
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapy for Diffuse Astrocytic and Oligodendroglial Tumors in Adults: ASCO-SNO Guideline.
    Mohile NA; Messersmith H; Gatson NT; Hottinger AF; Lassman A; Morton J; Ney D; Nghiemphu PL; Olar A; Olson J; Perry J; Portnow J; Schiff D; Shannon A; Shih HA; Strowd R; van den Bent M; Ziu M; Blakeley J
    J Clin Oncol; 2022 Feb; 40(4):403-426. PubMed ID: 34898238
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Radiotherapy in adult low-grade glioma: nationwide trends in treatment and outcomes.
    Nunna RS; Khalid S; Ryoo JS; Sethi A; Byrne RW; Mehta AI
    Clin Transl Oncol; 2021 Mar; 23(3):628-637. PubMed ID: 32691365
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Results of a policy of surveillance alone after surgical management of pediatric low grade gliomas.
    Fisher BJ; Leighton CC; Vujovic O; Macdonald DR; Stitt L
    Int J Radiat Oncol Biol Phys; 2001 Nov; 51(3):704-10. PubMed ID: 11597812
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low-grade astrocytomas: the prognostic value of fibrillary, gemistocytic, and protoplasmic tumor histology.
    Babu R; Bagley JH; Park JG; Friedman AH; Adamson C
    J Neurosurg; 2013 Aug; 119(2):434-41. PubMed ID: 23662821
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Patterns of care in elderly glioblastoma patients.
    Iwamoto FM; Reiner AS; Panageas KS; Elkin EB; Abrey LE
    Ann Neurol; 2008 Dec; 64(6):628-34. PubMed ID: 19107984
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anaplastic Glioma: Treatment Approaches in the Era of Molecular Diagnostics.
    Ruff MW; Uhm J
    Curr Treat Options Oncol; 2018 Oct; 19(12):61. PubMed ID: 30361986
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oligodendroglioma resection: a Surveillance, Epidemiology, and End Results (SEER) analysis.
    Alattar AA; Brandel MG; Hirshman BR; Dong X; Carroll KT; Ali MA; Carter BS; Chen CC
    J Neurosurg; 2018 Apr; 128(4):1076-1083. PubMed ID: 28498059
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment Outcomes in 1p19q Co-deleted/Partially Deleted Gliomas.
    McNamara MG; Jiang H; Lim-Fat MJ; Sahebjam S; Kiehl TR; Karamchandani J; Coire C; Chung C; Millar BA; Laperriere N; Mason WP
    Can J Neurol Sci; 2017 May; 44(3):288-294. PubMed ID: 28488951
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combined treatment modality for anaplastic oligodendroglioma: a phase II study.
    Jeremic B; Shibamoto Y; Gruijicic D; Milicic B; Stojanovic M; Nikolic N; Dagovic A; Aleksandrovic J
    J Neurooncol; 1999 Jun; 43(2):179-85. PubMed ID: 10533731
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Controversies in the treatment of low-grade astrocytomas and oligodendrogliomas.
    Levin VA
    Curr Opin Oncol; 1996 May; 8(3):175-7. PubMed ID: 8804814
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.